Acumen Pharmaceuticals, Inc. (ABOS)
Nasdaq: ABOS · Biological Products, (No Diagnostic Substances) · Newton, MA · filing with the SEC since 2013
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 26, 2026 | Mar 27, 2025 | Mar 26, 2024 | Mar 27, 2023 | Mar 28, 2022 | · |
| For lenders | ||||||
| Interest and dividend income | · | · | 10,791 | 2,392 | · | · |
| Interest and investment income | 7,447 | 14,317 | 10,791 | · | · | · |
| Research and development | 104,885 | 93,798 | 42,318 | 32,361 | 12,305 | 7,997 |
| General and administrative | 18,947 | 20,219 | 18,820 | 12,876 | 7,279 | 1,351 |
| Total operating expenses | 123,832 | 114,017 | 61,138 | 45,237 | 19,584 | 9,348 |
| Operating income | -123,832 | -114,017 | -61,138 | -45,237 | -19,584 | -7,912 |
| Interest expense | 4,224 | 4,068 | 581 | 0 | · | · |
| Interest income (expense), net | · | · | · | 2,392 | 84 | 1 |
| Other income (expense), net | -266 | -151 | -83 | -11 | 51 | · |
| Total non-operating income (expense) | 2,497 | 11,688 | 8,767 | 2,381 | -81,022 | 587 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -121,335 | -102,329 | -52,371 | -42,856 | -100,606 | -7,325 |
| Earnings per share, basic | -2.00 | -1.71 | -1.08 | -1.06 | -5.02 | · |
| Earnings per share, diluted | -2.00 | -1.71 | -1.08 | -1.06 | -5.02 | · |
| Earnings per share, basic and diluted | · | · | · | · | -5.02 | -17.48 |
| Weighted average shares, basic | 60,561,836 | 60,013,277 | 48,609,383 | 40,601,936 | 20,057,534 | · |
| Weighted average shares, diluted | 60,561,836 | 60,013,277 | 48,609,383 | 40,601,936 | 20,057,534 | · |
| Weighted average shares, basic and diluted | · | · | · | · | 20,057,534 | 419,124 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Interest and dividend income what its loans and securities earned
us-gaap:InterestIncomeOperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpenseInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted